Macfarlanes advises GHO Capital on its acquisition of Quotent Clinical

15 December 2015

Macfarlanes has advised specialist healthcare investor GHO Capital on its acquisition of Quotient Clinical, a provider of outsourced, early-stage drug development services to the pharmaceutical industry.

Quotient Clinical is headquartered in the UK and enables pharmaceutical and biotechnology customers to improve research and development productivity and accelerate drug development timelines.

The Macfarlanes team advised on all aspects of this transaction, including the equity investment from GHO, third party finance and tax structuring.  The Macfarlanes team comprised corporate M&A partners Alex Edmondson and Simon Perry, senior solicitor Steven Toy and solicitor Daniel Hobbs, finance partners Christopher Lawrence and Richard Fletcher, assisted by John Donnelly and solicitor Adam Caines, and tax senior solicitor Peter Abbott.